Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in primary sclerosing cholangitis
IRCT20200427047225N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Primary Sclerosing Cholangitis (PSC) comparing Fenofibrate with Placebo (2 arms). Primary endpoints: Pruritus, Serum alkaline phosphatase and 2 more. Started May 2020; status: completed.
02
Drugs
fenofibrate
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on IRCT20200427047225N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200427047225N1.